drugset / Trial / NCT00012038
Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
Phase 1/2
Completed
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of irofulven in treating patients who have progressive or recurrent astrocytoma, oligodendroglioma, or glioblastoma multiforme.
Timeline
- Start
- 2001-07
- Primary completion
- —
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | irofulven | Small molecule | — | Intravenous |